Concurrently, this specific protocol optimized the eradication of B-ALL cells within the murine bone marrow while concurrently minimizing the cytotoxic repercussions of chemotherapy on CD19 CAR-T cells (Figs. 1G–1I). Here, CD19 is linked to acute lymphoblastic leukemia.